Last Updated: Friday, July 25, 2014, 13:38
Biotechnology major Biocon has reported nine percent increase in its consolidated net profit to Rs 103 crore for the quarter ended June 30.
Last Updated: Monday, June 23, 2014, 22:16
Mazumdar-Shaw is the first Indian woman and fourth Indian to be conferred this prize.
Last Updated: Friday, April 25, 2014, 14:15
The company had posted a net profit of Rs 248.61 crore previous fiscal.
Last Updated: Wednesday, April 23, 2014, 23:14
Shaw used the Twitter again to apologise for her comments on Rohan, who is executive assistant to his father.
Last Updated: Wednesday, February 19, 2014, 11:43
India`s biotechnology queen Kiran Mazumdar-Shaw is the new chairperson of the prestigious Indian Institute of Management-Bangalore (IIM-B) as incumbent Mukesh Ambani of Reliance Industries stepped down.
Last Updated: Wednesday, February 19, 2014, 00:39
Top business school IIM Bangalore is set to see a change in its governing body with top industrialist Mukesh Ambani being replaced by Kiran Mazumdar Shaw as chairperson.
Last Updated: Thursday, January 23, 2014, 22:31
Kiran Mazumdar-Shaw of the country`s largest biotech research firm, Biocon Ltd, has been named winner of the 2014 Othmer Gold Medal, a top award of the US-based Chemical Heritage Foundation.
Last Updated: Thursday, January 23, 2014, 14:29
Bangalore-based biotech major Biocon Ltd Thursday reported 14.41 percent increase in its consolidated net profit for the third quarter ended December 31, 2013 at Rs 104.99 crore.
Last Updated: Friday, December 20, 2013, 17:28
Balakrishnan, who joined Infosys in 1991, was considered by some as the next chief executive officer after current CEO S D Shibulal retires in 2015.
Last Updated: Saturday, November 16, 2013, 19:37
If farmers are to become prosperous you need technology, she added.
Last Updated: Monday, September 09, 2013, 09:02
Economic growth has almost halved in pace to less than 5 percent in the past six years, a flood of cash leaving the country has led to a record current account deficit and combined with a rout of emerging markets.
Last Updated: Sunday, June 09, 2013, 11:13
The USD 500 million fine on Ranbaxy by US authorities after it pleaded guilty to "felony charges" for violating drug manufacturing norms is "a wake up call" for Indian pharmaceutical industry, according to Biocon Chairman and Manging Director Kiran Mazumdar-Shaw.
more videos >>